Literature DB >> 2105666

Spinal noradrenergic pathways and pressor responses to central angiotensin II.

J L Elghozi1, G A Head.   

Abstract

We have investigated the contribution of spinal noradrenergic (NA) pathways to the central pressor effects of angiotensin II (ANG II) in conscious rabbits with intact baroreceptors and after sinoaortic denervation (SAD). Very low intracisternal (ic) doses of ANG II [half maximum dose (ED50) = 6 x 10(-15) mol] produced increases in mean arterial pressure (MAP) and decreases in heart rate. Pressor responses to intracisternal ANG II were markedly reduced by 100 pmol of the ANG II antagonist [( Sar1, Ile8] ANG II, ic) and by intravenous prazosin, suggesting that central activation of ANG II receptors increased sympathetic vasoconstrictor tone. After SAD, the rabbits exhibited a 900-fold increase in sensitivity to ANG II (i.e., responded to very much lower doses, ED50 = 5 x 10(-18) mol). Intraspinal 6-hydroxydopamine (6-OHDA) injections given 1 mo earlier did not alter dose-response curves in baroreceptor-intact rabbits. However, the SAD-induced increase in sensitivity to ANG II was not observed in rabbits with depletion of spinal NA pathways. The results suggest intracisternal administration of ANG II activates two functionally distinct pathways: 1) a very sensitive site that utilizes NA projections to the spinal cord, and 2) a less sensitive site that uses non-NA descending pathways. Under normal baroreceptor input the former pressor pathway is completely inhibited. Thus the role of the central renin-angiotensin system may be of greater physiological importance in conditions where the baroreflex is suppressed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105666     DOI: 10.1152/ajpheart.1990.258.1.H240

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.

Authors:  D Pruneau; J M Luccarini; E Defrêne; J L Paquet; P Bélichard
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

2.  Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.

Authors:  T M Cocks; B K Kemp; D Pruneau; J A Angus
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Endothelium-dependent relaxations in sheep pulmonary arteries and veins: resistance to block by NG-nitro-L-arginine in pulmonary hypertension.

Authors:  B K Kemp; J J Smolich; B C Ritchie; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.

Authors:  V Deckert; D Pruneau; J L Elghozi
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

5.  Effects of the converting enzyme inhibitor trandolapril on short-term variability of blood pressure in essential hypertension.

Authors:  C Dutrey-Dupagne; A Girard; A Ulmann; J L Elghozi
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

6.  Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine.

Authors:  A P Stork; T M Cocks
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.

Authors:  A P Stork; T M Cocks
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

8.  Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery.

Authors:  E V Kilpatrick; T M Cocks
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.